BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23056171)

  • 21. Recent developments in protein and cell-targeted aptamer selection and applications.
    Liu J; You M; Pu Y; Liu H; Ye M; Tan W
    Curr Med Chem; 2011; 18(27):4117-25. PubMed ID: 21838693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.
    Ababneh N; Alshaer W; Allozi O; Mahafzah A; El-Khateeb M; Hillaireau H; Noiray M; Fattal E; Ismail S
    Nucleic Acid Ther; 2013 Dec; 23(6):401-7. PubMed ID: 24171482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Aptamers Against Cell Surface Markers Using Ligand-Guided Selection.
    Williams N; Patel R; Mallikaratchy P
    Methods Mol Biol; 2023; 2570():13-38. PubMed ID: 36156771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
    Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
    PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening and verification of ssDNA aptamers targeting human hepatocellular carcinoma.
    Lu B; Wang J; Zhang J; Zhang X; Yang D; Wu L; Luo Z; Ma Y; Zhang Q; Ma Y; Pei X; Yu H; Liu J
    Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):128-35. PubMed ID: 24300391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of DNA aptamers against penicillin G using Capture-SELEX for the development of an impedimetric sensor.
    Paniel N; Istamboulié G; Triki A; Lozano C; Barthelmebs L; Noguer T
    Talanta; 2017 Jan; 162():232-240. PubMed ID: 27837823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.
    Chen F; Hu Y; Li D; Chen H; Zhang XL
    PLoS One; 2009 Dec; 4(12):e8142. PubMed ID: 19997645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of an aptamer against mouse GP2 by SELEX.
    Hanazato M; Nakato G; Nishikawa F; Hase K; Nishikawa S; Ohno H
    Cell Struct Funct; 2014; 39(1):23-9. PubMed ID: 24334484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aptamers: selection, modification and application to nervous system diseases.
    Yang Y; Ren X; Schluesener HJ; Zhang Z
    Curr Med Chem; 2011; 18(27):4159-68. PubMed ID: 21838689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer biomarker discovery using DNA aptamers.
    Jin C; Qiu L; Li J; Fu T; Zhang X; Tan W
    Analyst; 2016 Jan; 141(2):461-6. PubMed ID: 26567694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of aptamers for molecular recognition and characterization of cancer cells.
    Tang Z; Shangguan D; Wang K; Shi H; Sefah K; Mallikratchy P; Chen HW; Li Y; Tan W
    Anal Chem; 2007 Jul; 79(13):4900-7. PubMed ID: 17530817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
    Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2'-O,4'-C-methylene-bridged/locked nucleic acid primer.
    Kasahara Y; Irisawa Y; Fujita H; Yahara A; Ozaki H; Obika S; Kuwahara M
    Anal Chem; 2013 May; 85(10):4961-7. PubMed ID: 23662585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in SELEX and application of aptamers in the central nervous system.
    Yang Y; Yang D; Schluesener HJ; Zhang Z
    Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
    Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
    Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.
    Bibby DF; Gill AC; Kirby L; Farquhar CF; Bruce ME; Garson JA
    J Virol Methods; 2008 Jul; 151(1):107-15. PubMed ID: 18433888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing.
    Cho M; Xiao Y; Nie J; Stewart R; Csordas AT; Oh SS; Thomson JA; Soh HT
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15373-8. PubMed ID: 20705898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.